North America Neurodegenerative Disease Market Size, Share & Trends Analysis Report By Disease Indication (Multiple Sclerosis, Parkinson's Disease, Alzheimer's Disease, Others), By Drug Type (Immunomodulator, Vesicular Monoamine Transporter 2 (VMAT2), Others), By Routes of Administration (Oral, Intravenous (IV) delivery, Others) and By Country (US, Canada) Forecasts, 2025-2033
Last Updated: November 14, 2022 |
Author: Debashree B |
Format: |
Report Code: SRHI3178DR |
Pages: 80